RBM7 and breast carcinoma: Above all, our findings uncovered a previously unidentified role of RBM7 in breast cancer metastasis via coupling MFGE8 splicing switch and NF-κB signaling activation, suggesting a new therapeutic target and prognostic predictor for breast cancer.